Avalyn Pharma Inc.

No buy/sell activity

Date	Name	Title	Shares	Value	Transaction
Sep 15, 2026	Meyer Robert J.	Director	31,182Stock Option (Right to Buy)	$1M	Grant / award
May 1, 2026	FMR LLC	See Remark 1	2,284,535Common Stock	$68.2M	Conversion
May 1, 2026	Novo Holdings A/S	10% Owner	555,555Voting Common Stock	$16.6M	Buy
May 1, 2026	Novo Holdings A/S	10% Owner	3,327,734Voting Common Stock	$99.3M	Conversion
May 1, 2026	Wellington Biomedical Innovation Master Investors (Cayman) II L.P.	10% Owner	1,275,486Common Stock	$38.1M	Conversion
May 1, 2026	SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	18,837,121Series D Convertible Preferred Stock	$562.1M	Conversion
May 1, 2026	SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	34,137,148Series C-1 Convertible Preferred Stock	$1B	Conversion
May 1, 2026	SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	555,555Common Stock	$16.6M	Buy
May 1, 2026	SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	2,263,608Common Stock	$67.5M	Conversion
May 1, 2026	Carroll Jill	Director	277,778Common Stock	$8.3M	Buy